QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
NASDAQ:BCLI

Brainstorm Cell Therapeutics News Headlines

$4.15
+0.09 (+2.22 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.05
Now: $4.15
$4.21
50-Day Range
$3.97
MA: $5.89
$7.88
52-Week Range
$3.80
Now: $4.15
$17.95
Volume532,852 shs
Average Volume1.23 million shs
Market Capitalization$148.24 million
P/E RatioN/A
Dividend YieldN/A
Beta0.37

Headlines

Brainstorm Cell Therapeutics (NASDAQ BCLI) News Headlines Today

Source:
SourceHeadline
Brainstorm Cell Therapeutics (NASDAQ:BCLI)  Shares Down 6.4% Brainstorm Cell Therapeutics (NASDAQ:BCLI) Shares Down 6.4%
americanbankingnews.com - February 25 at 8:18 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLISHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
prnewswire.com - February 24 at 8:24 PM
BrainStorm to Present at SVB Leerink 10th Global Healthcare ConferenceBrainStorm to Present at SVB Leerink 10th Global Healthcare Conference
finance.yahoo.com - February 23 at 8:19 AM
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) InvestigationBronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation
finance.yahoo.com - February 22 at 7:56 PM
FDA Concludes BrainStorms ALS Cell Therapy Lacks Substantial Data For Submission; Shares DropFDA Concludes BrainStorm's ALS Cell Therapy Lacks Substantial Data For Submission; Shares Drop
finance.yahoo.com - February 22 at 2:55 PM
BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development ProgramBrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
finance.yahoo.com - February 22 at 9:54 AM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Shares Gap Down to $6.90Brainstorm Cell Therapeutics (NASDAQ:BCLI) Shares Gap Down to $6.90
americanbankingnews.com - February 22 at 9:45 AM
Head to Head Survey: Enzon Pharmaceuticals (OTCMKTS:ENZN) versus Brainstorm Cell Therapeutics (NASDAQ:BCLI)Head to Head Survey: Enzon Pharmaceuticals (OTCMKTS:ENZN) versus Brainstorm Cell Therapeutics (NASDAQ:BCLI)
americanbankingnews.com - February 20 at 8:24 AM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) & Curis (NASDAQ:CRIS) Critical SurveyBrainstorm Cell Therapeutics (NASDAQ:BCLI) & Curis (NASDAQ:CRIS) Critical Survey
americanbankingnews.com - February 20 at 2:14 AM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Trading Down 6.3%Brainstorm Cell Therapeutics (NASDAQ:BCLI) Trading Down 6.3%
americanbankingnews.com - February 18 at 7:46 PM
We Think Brainstorm Cell Therapeutics (NASDAQ:BCLI) Needs To Drive Business Growth CarefullyWe Think Brainstorm Cell Therapeutics (NASDAQ:BCLI) Needs To Drive Business Growth Carefully
finance.yahoo.com - February 6 at 8:45 AM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Price Down 10.5%Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Price Down 10.5%
americanbankingnews.com - February 5 at 8:10 PM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Announces Quarterly  Earnings ResultsBrainstorm Cell Therapeutics (NASDAQ:BCLI) Announces Quarterly Earnings Results
americanbankingnews.com - February 5 at 1:53 PM
BCLI: Waiting for Guidance from FDA on Potential Path Forward for NurOwn® in ALS…BCLI: Waiting for Guidance from FDA on Potential Path Forward for NurOwn® in ALS…
finance.yahoo.com - February 5 at 1:03 PM
Why BrainStorm Cell Therapeutics Blasted 27.7% Higher TodayWhy BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
finance.yahoo.com - February 4 at 7:57 PM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Lifted to "Buy" at Maxim GroupBrainstorm Cell Therapeutics (NASDAQ:BCLI) Lifted to "Buy" at Maxim Group
americanbankingnews.com - February 4 at 2:56 PM
BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate UpdateBrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
finance.yahoo.com - February 4 at 9:52 AM
BCLI: Preclinical Data Shows NurOwn®-Derived Exosomes Effective in ARDS Model…BCLI: Preclinical Data Shows NurOwn®-Derived Exosomes Effective in ARDS Model…
finance.yahoo.com - January 25 at 2:49 PM
Brainstorm Cell Therapeutics: Whats Left After Recent Trial FailureBrainstorm Cell Therapeutics: What's Left After Recent Trial Failure
seekingalpha.com - January 20 at 3:58 PM
BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDSBrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS
finance.yahoo.com - January 20 at 10:58 AM
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS StudyBrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
finance.yahoo.com - December 18 at 7:38 AM
BrainStorm Announces NurOwn® Expanded Access ProgramBrainStorm Announces NurOwn® Expanded Access Program
finance.yahoo.com - December 14 at 8:57 AM
Need To Know: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Have Been Buying SharesNeed To Know: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Have Been Buying Shares
finance.yahoo.com - December 8 at 9:47 AM
Hedge Funds Aren’t Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) AnymoreHedge Funds Aren’t Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
finance.yahoo.com - November 27 at 12:56 AM
BCLI: Phase 3 ALS Trial Does Not Meet Primary Endpoint…BCLI: Phase 3 ALS Trial Does Not Meet Primary Endpoint…
finance.yahoo.com - November 19 at 12:51 PM
Why BrainStorm Cell Therapeutics Stock Imploded TodayWhy BrainStorm Cell Therapeutics Stock Imploded Today
finance.yahoo.com - November 17 at 1:25 PM
BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS StudyBrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study
finance.yahoo.com - November 17 at 8:25 AM
BrainStorm Cell recruits manufacturing partner for stem cell therapies for neurodegenerative disordersBrainStorm Cell recruits manufacturing partner for stem cell therapies for neurodegenerative disorders
seekingalpha.com - October 26 at 5:57 PM
Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorms U.S. Manufacturing FacilityRapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility
prnewswire.com - October 26 at 7:56 AM
Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing FacilityRapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility
finance.yahoo.com - October 26 at 7:56 AM
BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted…BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted…
finance.yahoo.com - October 23 at 9:50 AM
BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation ConferenceBrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation Conference
finance.yahoo.com - October 19 at 8:58 AM
BCLI: Phase 3 ALS Data Due Soon…BCLI: Phase 3 ALS Data Due Soon…
finance.yahoo.com - October 16 at 10:48 AM
Brainstorm Cell Therapeutics -7% despite earnings beatBrainstorm Cell Therapeutics -7% despite earnings beat
seekingalpha.com - October 15 at 5:33 PM
Brainstorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q3 2020 Results - Earnings Call TranscriptBrainstorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 15 at 5:33 PM
BrainStorm Cell Therapeutics EPS beats by $0.12BrainStorm Cell Therapeutics EPS beats by $0.12
seekingalpha.com - October 15 at 7:31 AM
BrainStorm to Present at Scientific Conferences in SeptemberBrainStorm to Present at Scientific Conferences in September
finance.yahoo.com - September 3 at 1:17 PM
BrainStorm Appoints Pharmaceutical Veteran Anthony Waclawski as Executive Vice President, Global Head of Regulatory AffairsBrainStorm Appoints Pharmaceutical Veteran Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs
finance.yahoo.com - September 2 at 12:11 PM
BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)
finance.yahoo.com - August 25 at 8:59 AM
BrainStorm Announces Publication of New Preclinical Data Supporting Proposed NurOwn® Mechanism in ALS, Progressive MS and Alzheimer's DiseaseBrainStorm Announces Publication of New Preclinical Data Supporting Proposed NurOwn® Mechanism in ALS, Progressive MS and Alzheimer's Disease
finance.yahoo.com - August 19 at 8:48 AM
We're Keeping An Eye On Brainstorm Cell Therapeutics' (NASDAQ:BCLI) Cash Burn RateWe're Keeping An Eye On Brainstorm Cell Therapeutics' (NASDAQ:BCLI) Cash Burn Rate
finance.yahoo.com - August 10 at 1:45 PM
BrainStorm to Present at the 40th Annual Canaccord Genuity Growth ConferenceBrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 10 at 8:45 AM
BCLI: Phase 3 ALS Data Expected by the End of November 2020…BCLI: Phase 3 ALS Data Expected by the End of November 2020…
finance.yahoo.com - August 7 at 1:31 PM
Brainstorm Cell Therapeutics Inc (BCLI) CEO Chaim Lebovits on Q2 2020 Results - Earnings Call TranscriptBrainstorm Cell Therapeutics Inc (BCLI) CEO Chaim Lebovits on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 1:41 PM
BrainStorm Cell Therapeutics EPS beats by $0.01BrainStorm Cell Therapeutics EPS beats by $0.01
seekingalpha.com - August 5 at 8:40 AM
BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate UpdateBrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update
finance.yahoo.com - August 5 at 8:40 AM
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D UpdateBrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
finance.yahoo.com - July 27 at 12:44 PM
5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta
finance.yahoo.com - July 23 at 4:47 PM
BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDSBrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
finance.yahoo.com - July 23 at 11:45 AM
BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
finance.yahoo.com - July 9 at 3:06 PM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.